EN
HI
Summary
As of 10 Nov, 2026, Nureca stock price is ₹302.1. During the trading session, the stock has moved between an intraday low of ₹298.70 and an intraday high of ₹309.90. Over the last 52 weeks, Nureca has traded between ₹204.00 and ₹376.00.
The stock has recorded a trading volume of 962 shares,. Its Average Traded Price (ATP) is ₹303.06, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 8 @ ₹302.10.
Nureca has an upper circuit limit of ₹317.20 and a lower circuit limit of ₹287.00. The total value traded stands at ₹2.92 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Nureca also offers a dividend yield of 0%.
Nureca Share Price Chart
Nureca Share Key Metrics
Volume
962.00
Market Cap
290.36 CR
LTQ@LTP
8@302.10
ATP
303.06
Var Margin
100 %
Circuit Range
287-317.2
Delivery %
0 %
Value
2.92 L
ASM/GSM
No
Market Lot
1
Nureca Fundamentals
P/E Ratio
60.31
P/B Ratio
1.53
Div. Yield
0
Sector P/E
53.21
Sector P/B
4.21
Sec. Div. Yield
0.05
Nureca Resistance and Support
Pivot 303.57
Resistance
First Resistance
308.44
Second Resistance
314.77
Third Resistance
319.64
Support
First Support
297.24
Second Support
292.37
Third Support
286.04
Nureca Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 309.89 | 302.1 | -0.72% | 309.89 | 298.7 |
| Sun Nov 08 2026 | 297 | 304.29 | 0.66% | 308.89 | 297 |
| Fri Nov 06 2026 | 306 | 302.29 | -0.30% | 309.7 | 295 |
Nureca Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-21 | Quarterly Results |
| 2025-11-10 | Buy Back of Shares |
| 2025-05-05 | Audited Results |
| 2025-01-24 | Quarterly Results |
Nureca News
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Credit Rating
CRISIL Ratings has assigned a long-term rating of BB+/Stable and a short-term rating of A4+ for Nureca's bank facilities. The total bank loan facilities rated amount to Rs.80 crore.
Nov 03 2026 16:45:12
Nureca Ltd - 543264 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nureca reported Q2 FY27 cons. revenue of Rs.58.53 crore (up 55% YoY) and net profit of Rs.4.05 crore (up 12% YoY). Online sales increased 55% YoY, contributing to 88% of total revenue.
Oct 21 2026 14:38:22
Read More
Nureca Management
| Name | Position |
|---|---|
| Aryan Goyal | Whole Time Director & Chief Executive Officer |
| Saurabh Goyal | Chairman & Managing Director |
Nureca Similar Stocks
Nureca FAQs
The Buying Price of Nureca share is 302.1 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Nureca stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Nureca, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Nureca shares is 60.31. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Nureca shares is 1.53. Useful to assess the stock's value relative to its book value.
To assess Nureca’s valuation compare Sector P/E, P/B which are 53.21 & 4.21 with sector averages, along with growth rates and financial metrics.
The Market Cap of Nureca is 290.36 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Nureca share price is 376.00 & 204.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Nureca belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in NURECA
